NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy

Affiliations

• ¹ Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California [email protected].
• ² Department of Radiology, San Francisco VA Medical Center, San Francisco, California.
• ³ Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
• ⁴ Department of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.
• ⁵ Department of Radiology, Moffitt Cancer Center, Tampa, Florida.
• ⁶ Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
• ⁷ Department of Medicine, Stanford University School of Medicine, Stanford, California.
• ⁸ NorCal CarciNET Community, Ripon, California.
• ⁹ Department of Radiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
• ¹⁰ Division of Gastroenterology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
• ¹¹ Department of Diagnostic Radiology, Division of Nuclear Medicine & Molecular Imaging, Oregon Health & Science University, Portland, Oregon.
• ¹² Division of Nuclear Medicine & Clinical Molecular Imaging, Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
• ¹³ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
• ¹⁴ Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario; and.
• ¹⁵ Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, Florida.